Skip to main contentSkip to footer
A finger pointing at a scan
Brighton & Sussex Medical School

Our staff

BSMS > About BSMS > Contact us > Staff > Clare Castledine

Clare Castledine

A photo of Clare Castledine wearing a jumper in front of a photo frame
BACKGROUND IMAGE FOR PANEL

Biography

Clare is a Senior Lecturer in the Department of Medical Education and the Director of Assessment for the undergraduate medical course. She is a consultant nephrologist at University Hospitals Sussex specialising in transplant medicine. She is a Fellow of the Royal College of Physicians and holds a PhD from the University of Bristol and a PG Cert from the University of Brighton.

Research

Clare is interested in understanding how we can make assessment fair and accessible for all. She supervises MD students and teaching fellows in both pedagogic and quality improvement projects.

Clare has undertaken health services research looking at variation in delivered care across regions to try and explain and address inequity.

BACKGROUND IMAGE FOR PANEL

Teaching 

Clare teaches renal medicine across the undergraduate medical course and on post graduate courses at BSMS for both nurses and doctors.

Clare heads up the assessment strategy for BSMS and delivers formative and summative assessment both for and of learning across the undergraduate course.

Until recently Clare was the training programme director for Kent Surrey and Sussex renal trainees and is now leading on quality assurance of renal training programmes nationally.

Selected publications

Clinical characteristics and outcomes of drug induced acute kidney injury cases. KI Reports. Awdishu L, CastledineC et al [in press]

Kirtchuk D, Wells G, Levett T, Castledine C, de Visser R. Understanding the impact of academic difficulties among medical students: A scoping review. Med Educ. 2021 Aug 27. doi:10.1111/medu.14624. Epub ahead of print. PMID: 34449921.

Chakraborty R, Lee K, brown F, Castledine C, Popoola J. Donor and recipient predictorof three year renal transplant outcomes.  KI Reports 2021. DOI10.1016/j.ekir.2021.03.740 

Ahmed F W, Kirresh O Z, Robinson A V, Sargent C, Castledine C, Chakera A. (March 15, 2021) A Retrospective Study Assessing the Effect of Diabetes on Mortality in Patients With COVID-19 at a Teaching Hospital in the United Kingdom. Cureus 13(3): e13902. doi:10.7759/cureus.13902

Castledine C, Tomlinson LA. Adjusting the Lens: Real World Outcomes in Nephrotic Syndrome.Kidney Int Rep. 2020 Dec 17;6(2):246-247. doi: 10.1016/j.ekir.2020.12.009. PMID: 33617605;PMCID: PMC7879198.

Hole B, Gilg J, Casula A, Methven S, Castledine C. Chapter 1 UK RenalReplacement Therapy Adult Incidence in 2016: National and Centre-specificAnalyses. Nephron. 2018;139 Suppl 1:13-46. doi: 10.1159/000490959. Epub 2018 Jul 10. PubMed PMID: 29990997.

Palamuthusingam D, Castledine C, Lawman S. Outcomes of immunosuppression in IgA nephropathy based on the oxford classification. Saudi J Kidney Dis Transpl.2018 Mar-Apr;29(2):341-350. doi: 10.4103/1319-2442.229292. PubMed PMID: 29657202.

Gilg J, Methven S, Casula A, Castledine C. UK Renal Registry 19th AnnualReport: Chapter 1 UK RRT Adult Incidence in 2015: National and Centre-specificAnalyses. Nephron. 2017;137 Suppl 1:11-44. doi: 10.1159/000481363. Epub 2017 Sep 29. PubMed PMID: 28930721.

Castledine C. Racial Disparity in Access to Home Therapies-We Have the Powerto Change. Perit Dial Int. 2017 Jan 2;37(1):4-5. doi: 10.3747/pdi.2016.00182.PubMed PMID: 28153963.

MacNeill SJ, Casula A, Shaw C, Castledine C. UK Renal Registry 18th AnnualReport: Chapter 2 UK Renal Replacement Therapy Prevalence in 2014: National and Centre-specific Analyses. Nephron. 2016;132 Suppl 1:41-68. doi:10.1159/000444816. Epub 2016 Apr 19. PubMed PMID: 27116553.

Read more here >